Iovance Biotherapeutics Inc. (NASDAQ:IOVA) has a beta value of 0.47 and has seen 2.28 million shares traded in the last trading session. The company, currently
During the last session, Iovance Biotherapeutics Inc. (NASDAQ:IOVA)’s traded shares were 2.69 million, with the beta value of the company hitting 0.48. At the end
In the last trading session, 2.35 million shares of the Iovance Biotherapeutics Inc. (NASDAQ:IOVA) were traded, and its beta was 0.48. Most recently the company’s
Iovance Biotherapeutics Inc. (NASDAQ:IOVA)’s traded shares stood at 2.86 million during the last session, with the company’s beta value hitting 0.51. At the close of
In the last trading session, 1.67 million Iovance Biotherapeutics Inc. (NASDAQ:IOVA) shares changed hands as the company’s beta touched 0.51. With the company’s per share
In last trading session, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) saw 3.96 million shares changing hands with its beta currently measuring 0.48. Company’s recent per share price
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) has a beta value of 0.48 and has seen 1.95 million shares traded in the last trading session. The company, currently
In the last trading session, 2.65 million shares of the Iovance Biotherapeutics Inc. (NASDAQ:IOVA) were traded, and its beta was 0.50. Most recently the company’s
Iovance Biotherapeutics Inc. (NASDAQ:IOVA)’s traded shares stood at 3.96 million during the last session, with the company’s beta value hitting 0.46. At the close of
In the last trading session, 4.13 million Iovance Biotherapeutics Inc. (NASDAQ:IOVA) shares changed hands as the company’s beta touched 0.46. With the company’s per share